Determinants of Longitudinal Change of Lung Function in Different Gender in a Large Taiwanese Population Follow-Up Study Categories: Original Investigation

Influence of indoor environmental conditions on airborne transmission and lifetime of sneeze droplets in a confined space: a way to reduce COVID-19 spread

Effects of indoor temperature (T∞) and relative humidity (RH∞) on the airborne transmission of sneeze droplets in a confined space were studied over the T∞ range of 15-30 °C and RH∞ of 22-62%. In addition, a theoretical evaporation model was used to estimate the droplet lifetime based on experimental data. The results showed that the body mass index (BMI) of the participants played an important role in the sneezing jet velocity, while the impact of the BMI and gender of participants was insignificant on the size distribution of droplets. At a critical relative humidity RH∞,crit of 46%, the sneezing jet velocity and droplet lifetime were roughly independent of T∞. At RH∞ < RH∞,crit, the sneezing jet velocity decreased by increasing T∞ from 15 to 30 °C, while its trend was reversed at RH∞ > RH∞,crit. The maximum spreading distance of aerosols increased by decreasing the RH∞ and increasing T∞, while the droplet lifetime increased by decreasing T∞ at RH∞ > RH∞,crit. The mean diameter of aerosolized droplets was less affected by T∞ than the large droplets at RH∞ < RH∞,crit, while the mean diameter and number fraction of aerosols were more influenced by RH∞ than the T∞ in the range of 46% ≤ RH∞ ≤ 62%. In summary, this study suggests suitable indoor environmental conditions by considering the transmission rate and lifetime of respiratory droplets to reduce the spread of COVID-19.

Neuroprotective strategies of cerebrolysin for the treatment of infants with neonatal hypoxic-ischemic encephalopathy

BACKGROUND

Perinatal asphyxia (PA) is a devastating neonatal condition characterized by a lack of oxygen supporting the organ systems. PA can lead to hypoxic-ischemic encephalopathy (HIE), a brain dysfunction due to oxygen deprivation with a complex neurological sequela. The pathophysiology of HIE and PA is not entirely understood, with therapeutic hypothermia being the standard treatment with only limited value. However, alternative neuroprotective therapies can be a potential treatment modality.

METHODS

In this review, we will characterize the biochemical mechanisms of PA and HIE, while also giving insight into cerebrolysin, a neuroprotective treatment used for HIE and PA.

RESULTS

We found that cerebrolysin has up to 6-month treatment window post-ischemic insult. Cerebrolysin injections of 0.1 ml/kg of body weight twice per week were found to provide gross motor and speech deficit improvement.

CONCLUSION

Our literature search emphasizes the positive effects of cerebrolysin for general improvement outcomes. Nevertheless, biomarker establishment is warranted to improve patient outcomes.